Particle.news

Download on the App Store

Serena Williams Says GLP-1 Helped Her Lose 31 Pounds, Announces Role With Telehealth Firm Ro

Her disclosure pairs a postpartum health decision with a paid partnership, fueling new discussion about prescription weight-loss care and promotion.

Image
Image
Image
Image

Overview

  • Williams says she began weekly GLP-1 injections in early 2024 after her second child and after she stopped breastfeeding, reporting a 31-pound loss over about a year.
  • She reports better blood sugar readings and less knee and joint strain since starting treatment and says she plans to continue the injections alongside training.
  • Williams is a paid ambassador for Ro, which offers GLP-1 programs, and her husband Alexis Ohanian is both an investor in the company and a member of its board.
  • Most interviews indicate she did not name the specific drug, though at least one outlet reported she used Zepbound, highlighting a discrepancy in coverage.
  • Her announcement has drawn mixed reactions on social media, with some praising her openness and others criticizing the endorsement of weight-loss medication.